Last edition
News about Clean Rooms
Recipharm launches new laboratory to expand analytical services offering
Global contract development and manufacturing organisation (CDMO), Recipharm, has announced the completion of a new analytical laboratory at its facility in Bengaluru. The new lab has been in full operation since August 1, 2021
Clean Rooms | 26/08/2021 | By Darshana | 582
Covid 19 treatment: Vir Biotechnology receives AustralianTGA marketing approval for sotrovimab
Vir Biotechnology announced the first marketing authorization, granted in Australia, for its first commercial product, sotrovimab, developed in partnership with GlaxoSmithKline (GSK). This announcement follows news shared by GSK Australia that the Australian Therapeutic Goods Administration (TGA) has granted provisional marketing authorization
Clean Rooms | 25/08/2021 | By Darshana | 248
Astellas Venture Management LLC, a wholly-owned venture capital subsidiary of Astellas Pharma Inc., and LabCentral, a launchpad for early-stage life-sciences startups, announced their collaboration on the "Future Innovator Prize" formerly known as the Astellas Golden Ticket Competition
Clean Rooms | 20/08/2021 | By Darshana | 406
The Drugs Controller General (India) has said that certain changes in the active substance of an approved drug may lead to change in drug specification and require validation of the manufacturing process
Clean Rooms | 27/07/2021 | By Darshana | 298
US FDA grants breakthrough therapy status to Roche's Venclexta
Roche announced that Venclexta (venetoclax) in combination with azacitidine has been granted Breakthrough Therapy Designation (BTD) by the US Food and Drug Administration (FDA) for the treatment of adult patients with previously untreated intermediate, high- and very high-risk myelodysplastic syndromes (MDS) based on the revised International Prognostic
Clean Rooms | 22/07/2021 | By Darshana | 292
Ipsen and IRLAB announced the signing of a licensing agreement, providing Ipsen exclusive worldwide development and commercial rights to mesdopetam, a novel dopamine D3-receptor antagonist. Mesdopetam is being assessed in phase IIb clinical trials as a potential treatment option
Clean Rooms | 17/07/2021 | By Darshana | 223
Orchard Therapeutics, a global gene therapy leader, and Pharming Group NV, a global and commercial stage biopharmaceutical company, have jointly announced a strategic collaboration to research, develop, manufacture and commercialize OTL-105
Clean Rooms | 02/07/2021 | By Darshana | 357
I Holland Present their Latest Tablet Tooling Developments at ACHEMA Pulse Next Week
I Holland, the world's best-known manufacturer of tablet punches and dies for the pharmaceutical and nutraceutical industries, has announced it will be exhibiting some of it most innovative products at ACHEMA Pulse from 15-19 June, including the new die table segment cleaning equipment
Clean Rooms | 09/06/2021 | By Darshana | 270
Lupin, Granules India recall around 9.71 lakh bottles of diabetes drug in the US
Lupin and Granules India are recalling close to 9.71 lakh bottles of generic diabetes drug in the US due to the possibility of the affected lot containing cancer-causing nitrosodimethylamine (NDMA) above the acceptable intake limit
Clean Rooms | 27/07/2020 | By Darshana | 444
Lupin's Pithampur Facilities Complete Successful UK MHRA Inspection
Pharma major Lupin Limited (Lupin) today announced the successful close out of the inspection carried out by the Medicines and Healthcare products Regulatory Agency (MHRA), the regulatory agency of the United Kingdom (UK)
Clean Rooms | 08/05/2020 | By Darshana | 642
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy